Strax

Autospela

Dr. Andrew Brohl at ASCO 2023: Abstract No. 9534

2 Visningar • 07/17/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

At ASCO 2023, Moffitt's Dr. Andrew Brohl discusses a phase 1b trial of IFx-Hu2.0, a novel personalized cancer vaccine, in checkpoint inhibitor resistant Merkel cell carcinoma and cutaneous squamous cell carcinoma.

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela